These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
371 related articles for article (PubMed ID: 25444906)
1. Adeno-associated virus-mediated cancer gene therapy: current status. Luo J; Luo Y; Sun J; Zhou Y; Zhang Y; Yang X Cancer Lett; 2015 Jan; 356(2 Pt B):347-56. PubMed ID: 25444906 [TBL] [Abstract][Full Text] [Related]
2. Cancer gene therapy using adeno-associated virus vectors. Park K; Kim WJ; Cho YH; Lee YI; Lee H; Jeong S; Cho ES; Chang SI; Moon SK; Kang BS; Kim YJ; Cho SH Front Biosci; 2008 Jan; 13():2653-9. PubMed ID: 17981740 [TBL] [Abstract][Full Text] [Related]
3. Vectrology of adeno-associated viruses (AAV). Skubis-Zegadło J; Stachurska A; Małecki M Med Wieku Rozwoj; 2013; 17(3):202-6. PubMed ID: 24296444 [TBL] [Abstract][Full Text] [Related]
4. The Adeno-associated Virus - A Safe and Promising Vehicle for Liverspecific Gene Therapy of Inherited and Non-inherited Disorders. Mak KY; Rajapaksha IG; Angus PW; Herath CB Curr Gene Ther; 2017; 17(1):4-16. PubMed ID: 28292253 [TBL] [Abstract][Full Text] [Related]
5. Adeno-associated virus vectors: potential applications for cancer gene therapy. Li C; Bowles DE; van Dyke T; Samulski RJ Cancer Gene Ther; 2005 Dec; 12(12):913-25. PubMed ID: 15962012 [TBL] [Abstract][Full Text] [Related]
6. Suppression of cancer growth in mice by adeno-associated virus vector-mediated IFN-beta expression driven by hTERT promoter. He LF; Wang YG; Xiao T; Zhang KJ; Li GC; Gu JF; Chu L; Tang WH; Tan WS; Liu XY Cancer Lett; 2009 Dec; 286(2):196-205. PubMed ID: 19564073 [TBL] [Abstract][Full Text] [Related]
10. Adeno-associated virus vectors for gene therapy of neurodegenerative disorders. During MJ; Leone P Clin Neurosci; 1995-1996; 3(5):292-300. PubMed ID: 8914796 [TBL] [Abstract][Full Text] [Related]
11. Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors. Shi W; Arnold GS; Bartlett JS Hum Gene Ther; 2001 Sep; 12(14):1697-711. PubMed ID: 11560765 [TBL] [Abstract][Full Text] [Related]
14. Promise of adeno-associated virus as a gene therapy vector for cardiovascular diseases. Bera A; Sen D Heart Fail Rev; 2017 Nov; 22(6):795-823. PubMed ID: 28589503 [TBL] [Abstract][Full Text] [Related]
16. [The development in the studies of AAV-mediated gene therapy in retina]. Zou X; Sui RF; Dong FT Zhonghua Yan Ke Za Zhi; 2011 Nov; 47(11):1049-52. PubMed ID: 22336072 [TBL] [Abstract][Full Text] [Related]
17. Retinal gene delivery by adeno-associated virus (AAV) vectors: Strategies and applications. Schön C; Biel M; Michalakis S Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):343-52. PubMed ID: 25615882 [TBL] [Abstract][Full Text] [Related]